198 related articles for article (PubMed ID: 2951523)
1. Immune response to murine neuroblastoma: effects of in vitro culture of the tumor. Mitogen and mixed lymphocyte culture responses, interleukin-2 production, suppression and natural killer activity.
Leclercq G; Willems J; Joniau M
J Clin Lab Immunol; 1986 Nov; 21(3):117-23. PubMed ID: 2951523
[TBL] [Abstract][Full Text] [Related]
2. NK activity in neuroblastoma bearing mice: in vivo versus in vitro propagated tumor variants.
Leclercq G; Willems J; Joniau M
J Clin Lab Immunol; 1987 Mar; 22(3):145-51. PubMed ID: 3612751
[TBL] [Abstract][Full Text] [Related]
3. Local and systemic immune response to inactivated Candida albicans in mice.
Scaringi L; Rosati E; Cornacchione P; Fettucciari K; Sabatini R; Biondi R; Mezzasoma L; Valiani M; D'Errico P; Marconi P
Nat Immun; 1995 Sep; 14(5-6):234-49. PubMed ID: 8933818
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
[TBL] [Abstract][Full Text] [Related]
5. The selective growth of murine newborn-derived suppressor cells and their probable mode of action.
Jadus MR; Parkman R
J Immunol; 1986 Feb; 136(3):783-92. PubMed ID: 2934478
[TBL] [Abstract][Full Text] [Related]
6. Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo.
Redlinger RE; Mailliard RB; Lotze MT; Barksdale EM
J Pediatr Surg; 2003 Mar; 38(3):301-7; discussion 301-7. PubMed ID: 12632339
[TBL] [Abstract][Full Text] [Related]
7. [Stimulation and suppression of cellular immunity in mice during liver regeneration].
Rakhmilevich AL; Sidorenko ON
Biull Eksp Biol Med; 1986 May; 101(5):591-4. PubMed ID: 2939891
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
Hinuma S; Naruo K; Shiho O; Tsukamoto K
Immunology; 1986 Oct; 59(2):251-9. PubMed ID: 3490435
[TBL] [Abstract][Full Text] [Related]
9. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppression associated with SJL/J murine lymphoma. I. Suppression of cell-mediated immune responses after tumor transplantation.
Kumar RK; Lykke AW; Penny R
J Natl Cancer Inst; 1981 Dec; 67(6):1269-75. PubMed ID: 6458725
[TBL] [Abstract][Full Text] [Related]
11. Active suppression of host-vs-graft reaction in pregnant mice. VI. Soluble suppressor activity obtained from decidua of allopregnant mice blocks the response to IL 2.
Clark DA; Chaput A; Walker C; Rosenthal KL
J Immunol; 1985 Mar; 134(3):1659-64. PubMed ID: 3871455
[TBL] [Abstract][Full Text] [Related]
12. Fractalkine (CX3CL1)- and interleukin-2-enriched neuroblastoma microenvironment induces eradication of metastases mediated by T cells and natural killer cells.
Zeng Y; Huebener N; Fest S; Weixler S; Schroeder U; Gaedicke G; Xiang R; Schramm A; Eggert A; Reisfeld RA; Lode HN
Cancer Res; 2007 Mar; 67(5):2331-8. PubMed ID: 17332365
[TBL] [Abstract][Full Text] [Related]
13. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.
Li T; Harada M; Tamada K; Abe K; Nomoto K
Anticancer Res; 1997; 17(6D):4259-68. PubMed ID: 9494518
[TBL] [Abstract][Full Text] [Related]
14. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
[TBL] [Abstract][Full Text] [Related]
15. Induction of gp70-specific suppressor T-cells in mice inoculated with virus-producing tumor cells.
Bluestone JA; Lopez C
J Natl Cancer Inst; 1982 Oct; 69(4):953-9. PubMed ID: 6214655
[TBL] [Abstract][Full Text] [Related]
16. Cellular mechanisms of interleukin-12-mediated neuroblastoma regression.
Redlinger RE; Shimizu T; Remy T; Alber S; Watkins SC; Barksdale EM
J Pediatr Surg; 2003 Feb; 38(2):199-204. PubMed ID: 12596103
[TBL] [Abstract][Full Text] [Related]
17. Natural suppressor (NS) activity from murine neonatal spleen is responsive to IFN-gamma.
Maier T; Holda JH
J Immunol; 1987 Jun; 138(12):4075-84. PubMed ID: 2953798
[TBL] [Abstract][Full Text] [Related]
18. [Effects of TCGF (T-cell growth factor) on experimental malignant glioma-specific killer T-cell].
Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
No Shinkei Geka; 1984 Feb; 12(2):141-50. PubMed ID: 6609319
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 2 deficiency in murine Leishmaniasis donovani and its relationship to depressed spleen cell responses to phytohemagglutinin.
Reiner NE; Finke JH
J Immunol; 1983 Sep; 131(3):1487-91. PubMed ID: 6224858
[TBL] [Abstract][Full Text] [Related]
20. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
Stitz L; Baenziger J; Pircher H; Hengartner H; Zinkernagel RM
J Immunol; 1986 Jun; 136(12):4674-80. PubMed ID: 3486908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]